Spotlight on women in pharma: Şeyda Atadan Memiş, Takeda
Is the launch environment really more competitive now?
Standing on the cusp of something great: How real-world data is poised to transform cancer care
Pricing and Market Access Outlook 2018
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.
Pricing and market access – facts versus fiction
Big data in Life Sciences: the time for strategy is now
Pricing & Market Access Outlook 2015/2016 Edition
Next-generation brand launches: Global health data and insights can transform your business